Key Points - Boston-based Eventide Asset Management sold 114,922 shares of Mirum Pharmaceuticals during the third quarter. - Despite the sale, the overall value of the position increased by about $50.70 million from the previous period thanks to a staggering stock price surge. - As of September…
Continue reading...